Showing results (391-400 of 486) with videos related to
Sort By:
Pageof 49
Molecular and Cellular Biology|November 10, 2010
Mammalian polycomb-like Pcl2/Mtf2 is a novel regulatory component of PRC2 that can differentially modulate polycomb activity both at the Hox gene cluster and at Cdkn2a genesXiangzhi Li, Kyo-Ichi Isono, Daisuke Yamada, et al.Nature Communications|April 7, 2019
Autophagy regulates lipid metabolism through selective turnover of NCoR1Tetsuya Saito, Akiko Kuma, Yuki Sugiura, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|December 13, 2021
Prognostication in Japanese patients with bacillus Calmette-Guérin-unresponsive non-muscle-invasive bladder cancer undergoing early radical cystectomyNobutaka Nishimura, Makito Miyake, Kota Iida, et al.International Journal of Clinical Oncology|February 10, 2022
Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world dataRyotaro Tomida, Makito Miyake, Ryoei Minato, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|May 9, 2024
J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in JapanEiji Kikuchi, Nozomi Hayakawa, Masashi Nakayama, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|February 2, 2024
Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in JapanYuki Kita, Hikari Otsuka, Katsuhiro Ito, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|January 19, 2024
Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second-line treatment with tyrosine kinase inhibitor following first-line immune-oncology combination therapyYuto Matsushita, Takahiro Kojima, Takahiro Osawa, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|March 1, 2024
Validation study on the 2 mm diameter cutoff in lymph node-positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real-world data analysis from a Japanese cohortMasashi Kato, Masaki Shiota, Takahiro Kimura, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|January 26, 2022
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burdenYoshiyuki Nagumo, Mizuki Onozawa, Takahiro Kojima, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|November 30, 2022
C-reactive protein as a prognostic predictor for non-muscle invasive bladder cancer after intravesical bacillus Calmette-Guérin therapy: A Japan Urological Oncology Group study analysisRyoma Nishikawa, Makito Miyake, Shuichi Morizane, et al.Pageof 49